[Experience in the use of present day immunomodulators for prophylaxis of exacerbations of chronic adenoiditis and development of pharyngeal tonsil hypertrophy in poor health children].
Children having frequent acute respiratory infections and chronic adenoiditis were given immunomodulators (ridostin, IRS-19, polyoxidonium). As a result of such prophylaxis, respiratory infections and exacerbations of chronic adenoiditis occurred in poor-health children 2-2.5 times less frequently. Their local immunity and nonspecific resistance improved. Thus, modern immunomodulators can be used in poor-health children with chronic adenoiditis to prevent acute respiratory viral infection and development of pharyngeal tonsil hypertrophy as well as to treat them.
Vavilova
V P
VP
D000234:Adenoids; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006801:Humans; D006984:Hypertrophy / Q000473:pathology; D007369:Interferon Inducers / Q000627:therapeutic use*; D014066:Palatine Tonsil / Q000473:pathology*; D010254:Paranasal Sinus Diseases / Q000517:prevention & control*; D012330:RNA, Double-Stranded / Q000627:therapeutic use*; D012331:RNA, Fungal / Q000627:therapeutic use*; D012008:Recurrence
D000276:Adjuvants, Immunologic; D007369:Interferon Inducers; D012330:RNA, Double-Stranded; D012331:RNA, Fungal; C076741:ridostin